Blackstone Signs Definitive Agreement to Acquire Takeda Consumer Healthcare Company
TOKYO (August 24th, 2020) – Blackstone (NYSE: BX) announced today that funds managed by The Blackstone Group Inc. and its affiliates (collectively, “Blackstone”) have entered into a definitive agreement to acquire Takeda Consumer Healthcare Company Limited (“TCHC”), a subsidiary of Takeda Pharmaceutical Company Limited and a leading provider of over-the-counter medicines in Japan.
For more than 66 years, TCHC’s flagship vitamin drug Alinamin has been a staple product in Japanese households. In addition to Alinamin vitamin tablets and drinks, TCHC offers a platform of other over-the-counter products, including Benza Block, a leading symptom based cold remedy.
Atsuhiko Sakamoto, Head of Private Equity in Blackstone Japan, commented: “We are privileged to announce this partnership and invest in the company’s plans to become the leading consumer healthcare business in Japan. TCHC is well-positioned to grow its established brands in Japan and launch new and expanded product offerings. We see tremendous potential for TCHC in Japan and throughout Asia, and we are confident that Blackstone’s global network and expertise in the sector can accelerate TCHC’s growth.”
Milano Furuta, Chairman of the Board, Takeda Consumer Healthcare Company, said: “Throughout decades, TCHC’s brands including Alinamin have earned the trust and confidence of consumers in Japan. We believe the active and strategic investment by Blackstone will enable TCHC to maximize its potential. Blackstone is one of the world’s leading investment firms and has rich experience in the healthcare sector, and we are confident this will help TCHC further develop its products and brands and strengthen the business overall.”
The transaction marks Blackstone’s second private equity transaction in Japan’s healthcare sector following the acquisition of AYUMI Pharmaceutical in 2019.
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. is acting as exclusive financial advisor to Blackstone, while Simpson Thacher & Bartlett LLP and Anderson Mori & Tomotsune are acting as legal advisors.
Blackstone is one of the world’s leading investment firms. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our asset management businesses, with $564 billion in assets under management, include investment vehicles focused on private equity, real estate, public debt and equity, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com. Follow Blackstone on Twitter @Blackstone.
Global Public Affairs, Blackstone
+852 9731 9726